Arthritis patients taking newer treatments do not have an overall increased cancer risk, research finds

ScienceDaily (May 27, 2011) — Newer biologic treatments, including infliximab (Remicade), adalimumab (Humira), certolizumab pegol (Cimzia), golimumab (Simponi) and etanercept (Enbrel), used in patients with arthritis do not increase the risk of cancer, according to data from over 13,000 patients presented at the EULAR 2011 Annual Congress.

See Also:Health & MedicineArthritisBreast CancerCancerColon CancerCrohn's DiseaseOvarian CancerReferenceArthritisRheumatoid arthritisCOX-2 inhibitorPsoriasis

Only three percent (n